Bristol-Myers (BMY), AstraZeneca (AZN) Announce FDA Acceptance of NDA for Combination of ONGLYZA and ER Metformin
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. FDA has accepted for review a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
